The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Regenxbio Inc shares valued at $148,504 were purchased by VITTAL VASISTA on Dec 30 ’24. At $7.41 per share, VITTAL VASISTA acquired 20,041 shares.
Also, KARABELAS ARGERIS N sold 10,000 shares, netting a total of over 101,052 in proceeds. Following the sale of shares at $10.11 each, the insider now holds 11,286 shares.
Before that, KARABELAS ARGERIS N had sold 10,000 shares from its account. In a trade valued at $115,588, the Director traded Regenxbio Inc shares for $11.56 each. Upon closing the transaction, the insider’s holdings decreased to 10,000 shares, worth approximately $81710.64.
As published in a research note from Goldman on February 11, 2025, Regenxbio Inc [RGNX] has been rated down from a Buy to a Neutral and the price target has been revised to $14 from $38.
Analyzing RGNX Stock Performance
During the last five days, there has been a drop of approximately -24.66%. Over the course of the year, Regenxbio Inc shares have dropped approximately -6.34%. Shares of the company reached a 52-week high of $10.59 on 05/02/25 and a 52-week low of $5.03 on 04/09/25. A 50-day SMA is recorded $7.32, while a 200-day SMA reached $9.28.
Support And Resistance Levels for Regenxbio Inc (RGNX)
According to the 24-hour chart, there is a support level at 6.84, which, if violated, would cause prices to drop to 6.44. In the upper region, resistance lies at 7.79. The next price resistance is at 8.33. RSI (Relative Strength Index) is 44.18 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.33, which suggests the price will decrease in the coming days. Percent R is at 70.68%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
